WELCOME TO THE PREMIER WEIGHT LOSS CLINIC IN CALIFORNIA!
At Ideal Protocol, we’ve been a leading provider of the Ideal Protein weight loss program since 2012, helping thousands achieve their weight and health goals. While the Ideal Protein Protocol remains our foundation, we’ve enhanced it with additional food options and support services.
TRUE CHANGE
Following a diet plan and temporarily changing eating habits, results in temporary weight loss. We aim to transform your metabolism and mindset, helping you break free from the cycle of dieting and weight regain. Sustainable change involves adjusting dietary habits and most of all, reshaping your personal mindset.
CORE PROGRAM
Dietary Guidance & Support:
We combine meal replacements with whole foods to control calories and optimize macronutrient ratios—low carbs, low fat, and ample protein. This balance shifts your metabolism from sugar burning to fat burning by regulating key hormones like insulin and glucagon.
Mindset Coaching:
Daily content and expert coaching help you navigate challenges, build awareness, and reshape your dietary mindset for lasting transformation.
CORE PLUS PROGRAM
For clients needing help with consistency, our Core Plus Program includes everything in the Core Program plus daily exogenous ketones. These ketones help suppress appetite and boost energy, providing additional support for those with intermittent struggles on the Core Program.
CORE MED PROGRAM
Our Core Med Program builds on the Core Program by incorporating medical assistance for those facing significant challenges with appetite control. Clients consult with our partner MD to explore GLP-1 medications like Semaglutide or Tirzepatide (e.g., Ozempic, Monjuaro). If prescribed, these medications are combined with our program to support mindset shifts, healthy eating habits, and lean mass retention.
OUR GOAL
Help clients make lasting dietary lifestyle changes, reducing the need for chronic dieting or long-term medication. Weekly coaching sessions allow us to monitor your body composition closely and avoid critical muscle loss. Daily mindset content coupled with one-on-one coaching provides the best opportunity for lasting change.
To give you a glimpse of the mind and body transformations our clients experience, we invite you to watch this testimonial video featuring Sue.
Curious about prescription weight loss injections? Semaglutide or "Ozempic", Tirzepatide or "Monjuaro" watch these videos:
Medicine alone is not the answer and we can help you navigate the additional changes needed.
See how others have achieved
SUCCESS
recognition rewards
How it Works
Reset BODY. Reset MIND. Reset POSSIBLE.
With the 3-Phase Ideal Protocol.
Reset BODY to BURN FAT and LOSE THE WEIGHT.
By restricting carbohydrate intake, the Weight Loss Phase is designed to optimize fat loss through ketosis (a safe and natural state in which the body mobilizes stored fat as its alternative energy source). You’ll remain in Phase 1 until you have reached your weight loss goal.
Reset MIND to MAINTAIN a HEALTHY WEIGHT and build HEALTHY HABITS.
Following weight loss, the body fights to regain lost weight. This “energy gap”, where more calories are desired than required, makes weight loss difficult to manage and maintain. Stabilization is about narrowing this gap by adjusting the intake of protein/fat/carbs to effectively manage hunger, promote greater satiety and maintain weight loss. Weekly follow-up sessions over the course of two months or more are designed to monitor carbohydrate reintroduction and track weight.
Reset POSSIBLE and live your FULLEST, HEALTHIEST, BEST LIFE yet.
For the first 12 months following Stabilization, you will continue to receive education and support from your coach and clinic. It’s also recommended to “check in” regularly with your coach during this period. For all of those in Maintenance, two semi-annual “tune-ups” are strongly encouraged.
Products
Proven Weight Loss and Improved Metabolic Health
View our collection of clinical trials, case studies and peer-reviewed research.
“Effect of Ideal Protein versus low-fat diet for weight loss: A randomized controlled trial”
Camilo A. Fernandez, MD, Kaitlin Potts, Lydia A. Bazzano, MD, PhD
A new, peer-reviewed study published in Obesity Science & Practice, led by Tulane University, compared the Ideal Protein dietary behavioral intervention (IP system) to a standard, guideline-based, low-calorie, low-fat (LCLF) dietary behavioral intervention.¹·²
The 3-month trial assigned 192 adult participants with body mass index (BMI) ≥30 and ≤49 kg/m2, to either the Ideal Protein Phase 1 diet or LCLF diet interventions.¹
Reported Primary Endpoint (body weight):
“The IP system resulted in statistically significant greater weight loss among men and women with obesity and additional risk factors for cardiovascular disease (CVD).” ¹
(Comparison of mean weight loss in kg between participants in the IP group vs the LCLF group, at 3 months). Clustered column graph depicting average weight at baseline and 3-month follow-up for each dietary intervention group, respectively.
Reported Secondary Endpoints:
Although both groups saw improvements in several cardiometabolic risk factors, there were significant between-group differences favoring the IP Group, which “experienced greater improvements in waist and hip circumference, total cholesterol, and triglycerides.”¹
Results of the remaining secondary outcomes for the IP group were equal to or exhibited more favorable trends than the LCLF group, although some did not reach statistical significance in either group.
The study concludes that “this 3-month randomized, parallel group trial showed that the IP system resulted in greater weight loss and reduction in several CVD risk factors than a guideline-based LCLF dietary behavioral intervention among black and white adults with obesity and additional CVD risk factors. Thus, the IP system appears to be a safe and efficacious way to lose weight and reduce CVD risk factors among men and women with obesity and additional CVD risk factors. Further research is warranted to examine outcomes over the longer term.”¹𝄒²
Funding was provided by a grant from Ideal Protein Laboratories COP Inc, Quebec, Canada to Tulane University, School of Public Health and Tropical Medicine.
¹Fernandez CA, Potts K, Bazzano LA. Effect of ideal protein versus low-fat diet for weight loss: a randomized controlled trial. Obes Sci Pract. 2021; 1- 9. doi:10.1002/osp4.567
² Jensen MD, et.al.. 2013 AHA/ACC/TOS guideline for the management of overweight and obesity in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and The Obesity Society. J Am Coll Cardiol. 2014;63:2985-3023.
“A randomized controlled trial of pharmacist-led therapeutic carbohydrate and energy restriction in type 2 diabetes”
Jonathan P. Little, PhD. Sean McKelvey, Cody Durrer, PhD
A recent randomized, controlled clinical study, led by the University of British Columbia and sponsored by the Institute for Personalized Therapeutic Nutrition, evaluates the impact of a Pharmacist-led therapeutic carbohydrate restricted diet (Pharm-TCR) on type 2 diabetes (T2D). Participants in the Pharm-TCR group were asked to follow the Ideal Protein weight loss diet plan, supplemented with whole foods.¹
The primary objective of the study, published in Nature Communications, was to determine if a Pharm-TCR diet can safely reduce and/or eliminate the use of glucose-lowering medications and lead to improvements in A1C, body composition, cardiometabolic health, and quality of life.² Of the 188 patients that participated in the 12-week study, 98 patients followed a Pharm-TCR diet, and 90 patients received treatment-as-usual.*
Reported Primary Outcomes for Pharm TCR patients after 12 weeks
of patients experienced discontinuation of glucose lowering medication (p < 0.0001)
reduction in A1C (p < 0.0001)
SECONDARY OUTCOMES:
reduction in fasting plasma glucose (p < 0.0001)
reduction in triglycerides (p < 0.0001)
reduction in total body weight* (p < 0.0001)
reduction in waist circumference (p < 0.0001)
reduction in BMI (p < 0.0001)
reduction in body fat percentage (p < 0.0001)
As stated in the 2019 Diabetes Care report, “low-carbohydrate eating patterns, especially very low-carbohydrate (VLC) eating patterns, have been shown to reduce A1C and the need for antihyperglycemic medications.”³
*Treatment-as usual defined as: given information pamphlets on diet and lifestyle conforming with 2013 Diabetes Canada (formerly the Canadian Diabetes Association) Clinical Practice Guidelines.
¹ Durrer, C., McKelvey, S., Singer, J. et al. A randomized controlled trial of pharmacist-led therapeutic carbohydrate and energy restriction in type 2 diabetes. Nat Commun 12, 5367 (2021). https://doi.org/10.1038/s41467-021-25667-4
² Durrer, C., McKelvey, S., Singer, J. et al. Pharmacist-led therapeutic carbohydrate restriction as a treatment strategy for type 2 diabetes: the Pharm-TCR randomized controlled trial protocol. Trials 20, 781 (2019). https://doi.org/10.1186/s13063-019-3873-7
³ Evert AB, Dennison M, Gardner CD, Garvey WT, Lau KHK, MacLeod J, et al. Nutrition therapy for adults with diabetes or prediabetes: a consensus report. Diabetes Care. (2019) 42:731–54. doi: 10.2337/dci19-0014
“Ketogenic, Hypocaloric Diet Improves Nonalcoholic Steatohepatitis”
Yuliya Belopolsky, MD, Claus J. Fimmel, MD, David Davidson, MD
The goal of this study was to examine the impact of the Ideal Protein Protocol on metabolic parameters and markers of liver disease in patients with non-alcoholic steatohepatitis.
The findings highlight the beneficial effects of the Ideal Protein Protocol on liver enzymes and a marker of liver fibrosis among a group of patients with NASH⁸’⁹
Experts estimate that the prevalence of NASH is up to 12%, over 16 million US adults, with estimates of a 63% increase by year 2030. ¹⁰
⁸ Belopolsky Y, Khan MQ, Sonnenberg A, Davidson DJ, Fimmel CJ. Ketogenic, Hypocaloric Diet Improves Nonalcoholic Steatohepatitis. J Transl Int Med. 2020;8(1):26-31. Published 2020 May 9. doi:10.2478/jtim-2020-0005
⁹ Promrat K, Kleiner DE, Niemeier HM, et al. Randomized controlled trial testing the effects of weight loss on nonalcoholic steatohepatitis. Hepatology. 2010;51(1):121-129. doi:10.1002/hep.23276
¹⁰ Estes C, Razavi H, Loomba R, Younossi Z, Sanyal AJ. Modeling the epidemic of nonalcoholic fatty liver disease demonstrates an exponential increase in burden of disease. Hepatology. 2018;67(1):123-133. doi:10.1002/hep.29466
Dr. Davidson is a member of Ideal Protein’s Medical Advisory Board.
Inflammation & Heart Health
Krista N. Bohlen, PharmD, Amy Krie, MD, Yueshan Hu, PhD
A 19-week study with the Avera Cancer Institute reported a 40% reduction in C-reactive protein for patients who completed the Ideal Protein Protocol. The study also reported a rapid decline in resting fasting insulin and a mean weight loss of 19.9% body fat. ⁶
Studies show increased CRP levels are associated with a higher risk for inflammatory conditions. ⁷
⁶ Bohlen, Krista & Krie, Amy & Hu, Yueshan & Ageton, Cheryl & Nickles, Heidi & Norfolk, Daniel & Kittelsrud, Julie & Thomes, Reggie & Fahrendorf, Adam & Muth, Jessica & Rojas-Espaillat, Luis & Davies, Gareth. (2013). Low Carbohydrate Dietary Intervention Improves Insulin, Hormonal Levels and Inflammatory Markers in Early Stage, Postmenopausal Breast Cancer Survivors. Cancer Research. 73. 10.1158/0008-5472.SABCS13-PD2-5.
⁷ Pepys MB, Hirschfield GM. C-reactive protein: a critical update. J Clin Invest. 2003;112(2):299. doi:10.1172/JCI200318921C
3-year Weight Maintenance & Healthcare Savings
Timothy Logemann, MD, David K. Murdock, MD, MS, Kelly O’Heron, RD, Adam Hoffmann
A study conducted by Aspirus, reported that after 3 years, participants who completed the Ideal Protein Protocol maintained an average weight loss of 12.8%, resulting in an 18% reduction in overall average claim care costs, saving an average of $916.97 per participant, per year. ²
A study published by The American Journal of Clinical Nutrition reports that if individuals can succeed at maintaining their weight loss for 2 or more years, they can reduce their risk of subsequent regain by nearly 50%.³
² Effect of The Ideal Protein Weight Loss Protocol on Employee Health Care Costs, By: Timothy Logemann, MD; David K. Murdock, MD; Kelly O’Heron, RD
³ Rena R Wing, Suzanne Phelan, Long-term weight loss maintenance, The American Journal of Clinical Nutrition, Volume 82, Issue 1, July 2005, Pages 222S, 225S, https://doi.org/10.1093/ajcn/82.1.222S
Dr. Logemann is a member of Ideal Protein’s Medical Advisory Board.
“Effect of the Ideal Protein Weight Loss Method on Weight Loss and Metabolic Parameters”
Timothy Logemann, MD, David K. Murdock, MD, MS, Kelly O’Heron, RD
According to a study conducted and published by Aspirus, an eight-hospital health system in Wisconsin and Michigan, entitled Effect of the Ideal Protein Weight Loss Method on Weight Loss and Metabolic Parameters,¹ 233 patients completed at least 12 weeks of the Protocol. The 12-week results were presented at the Cleveland Clinic’s 9th Annual Obesity Summit and at the Annual Scientific Meeting of the National Obesity Society.
Our peer-reviewed, published research demonstrates that, among patients who completed the study, metabolic health can be improved in as little as 12 weeks.
15% ↓
BMI
14% ↓
Total Body Weight*
86% ↓
Dieter Compliance
45% ↓
Triglycerides
14% ↓
Cholesterol
14% ↓
Total Body Weight*
14% ↓
Fasting Glucose
13% ↓
LDL
Study Concludes: The Ideal Protein Protocol produces improvements in blood pressure, lipid profile, particularly in regard to triglyceride levels and fasting glucose levels. The findings suggest that due to the successful weight loss reported, the Protocol could help with cardiovascular risk.
* Total Body Weight -3.5lbs/wk for men and -2.4lbs./wk for women
¹ Effect of the Ideal Protein Weight Loss Method on Weight Loss and Metabolic Parameters By: Timothy Logemann, MD; David K. Murdock, MD, MS; Kelly O’Heron, RD & Adam Hoffmann
Dr. Logemann is a member of Ideal Protein’s Medical Advisory Board.
Robust Weight Loss with Lean Mass Preserved
Franklin M. Douglis, MD
After 16 weeks on the Ideal Protein Protocol, males lost an average of 25% fat mass while preserving 98% lean body mass and females lost an average 24% of fat mass while preserving 95% lean body mass.⁴
A 2014 Obesity Review states: “Maximizing fat loss while preserving lean tissue mass and function is a central goal of modern obesity treatments. A widely cited rule guiding expected loss of lean tissue as fat-free mass (FFM) states that approximately one-fourth of weight loss will be FFM (i.e. ΔFFM/ΔWeight = ∼0.25), with the remaining three-fourths being fat mass.” 5
⁴ Frank Douglis, MD, Ideal Protein Data Analysis, 2016.
⁵ Heymsfield SB, Gonzalez MC, Shen W, Redman L, Thomas D. Weight loss composition is one-fourth fat-free mass: a critical review and critique of this widely cited rule. Obes Rev. 2014;15(4):310-321. doi:10.1111/obr.12143
Dr. Douglis is an Executive Medical Board Member and Chief Medical Advisor for Ideal Protein.
A new, peer-reviewed study published in Obesity Science & Practice, led by Tulane University, compared the Ideal Protein dietary behavioral intervention (IP system) to a standard, guideline-based, low-calorie, low-fat (LCLF) dietary behavioral intervention.¹·²
The 3-month trial assigned 192 adult participants with body mass index (BMI) ≥30 and ≤49 kg/m2, to either the Ideal Protein Phase 1 diet or LCLF diet interventions.¹
Reported Primary Endpoint (body weight):
“The IP system resulted in statistically significant greater weight loss among men and women with obesity and additional risk factors for cardiovascular disease (CVD).” ¹
(Comparison of mean weight loss in kg between participants in the IP group vs the LCLF group, at 3 months). Clustered column graph depicting average weight at baseline and 3-month follow-up for each dietary intervention group, respectively.
Reported Secondary Endpoints:
Although both groups saw improvements in several cardiometabolic risk factors, there were significant between-group differences favoring the IP Group, which “experienced greater improvements in waist and hip circumference, total cholesterol, and triglycerides.”¹
Results of the remaining secondary outcomes for the IP group were equal to or exhibited more favorable trends than the LCLF group, although some did not reach statistical significance in either group.
The study concludes that “this 3-month randomized, parallel group trial showed that the IP system resulted in greater weight loss and reduction in several CVD risk factors than a guideline-based LCLF dietary behavioral intervention among black and white adults with obesity and additional CVD risk factors. Thus, the IP system appears to be a safe and efficacious way to lose weight and reduce CVD risk factors among men and women with obesity and additional CVD risk factors. Further research is warranted to examine outcomes over the longer term.”¹𝄒²
Funding was provided by a grant from Ideal Protein Laboratories COP Inc, Quebec, Canada to Tulane University, School of Public Health and Tropical Medicine.
¹Fernandez CA, Potts K, Bazzano LA. Effect of ideal protein versus low-fat diet for weight loss: a randomized controlled trial. Obes Sci Pract. 2021; 1- 9. doi:10.1002/osp4.567
² Jensen MD, et.al.. 2013 AHA/ACC/TOS guideline for the management of overweight and obesity in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and The Obesity Society. J Am Coll Cardiol. 2014;63:2985-3023.
A recent randomized, controlled clinical study, led by the University of British Columbia and sponsored by the Institute for Personalized Therapeutic Nutrition, evaluates the impact of a Pharmacist-led therapeutic carbohydrate restricted diet (Pharm-TCR) on type 2 diabetes (T2D). Participants in the Pharm-TCR group were asked to follow the Ideal Protein weight loss diet plan, supplemented with whole foods.¹
The primary objective of the study, published in Nature Communications, was to determine if a Pharm-TCR diet can safely reduce and/or eliminate the use of glucose-lowering medications and lead to improvements in A1C, body composition, cardiometabolic health, and quality of life.² Of the 188 patients that participated in the 12-week study, 98 patients followed a Pharm-TCR diet, and 90 patients received treatment-as-usual.*
Reported Primary Outcomes for Pharm TCR patients after 12 weeks
of patients experienced discontinuation of glucose lowering medication (p < 0.0001)
reduction in A1C (p < 0.0001)
SECONDARY OUTCOMES:
reduction in fasting plasma glucose (p < 0.0001)
reduction in triglycerides (p < 0.0001)
reduction in total body weight* (p < 0.0001)
reduction in waist circumference (p < 0.0001)
reduction in BMI (p < 0.0001)
reduction in body fat percentage (p < 0.0001)
As stated in the 2019 Diabetes Care report, “low-carbohydrate eating patterns, especially very low-carbohydrate (VLC) eating patterns, have been shown to reduce A1C and the need for antihyperglycemic medications.”³
*Treatment-as usual defined as: given information pamphlets on diet and lifestyle conforming with 2013 Diabetes Canada (formerly the Canadian Diabetes Association) Clinical Practice Guidelines.
¹ Durrer, C., McKelvey, S., Singer, J. et al. A randomized controlled trial of pharmacist-led therapeutic carbohydrate and energy restriction in type 2 diabetes. Nat Commun 12, 5367 (2021). https://doi.org/10.1038/s41467-021-25667-4
² Durrer, C., McKelvey, S., Singer, J. et al. Pharmacist-led therapeutic carbohydrate restriction as a treatment strategy for type 2 diabetes: the Pharm-TCR randomized controlled trial protocol. Trials 20, 781 (2019). https://doi.org/10.1186/s13063-019-3873-7
³ Evert AB, Dennison M, Gardner CD, Garvey WT, Lau KHK, MacLeod J, et al. Nutrition therapy for adults with diabetes or prediabetes: a consensus report. Diabetes Care. (2019) 42:731–54. doi: 10.2337/dci19-0014
The goal of this study was to examine the impact of the Ideal Protein Protocol on metabolic parameters and markers of liver disease in patients with non-alcoholic steatohepatitis.
The findings highlight the beneficial effects of the Ideal Protein Protocol on liver enzymes and a marker of liver fibrosis among a group of patients with NASH⁸’⁹
Experts estimate that the prevalence of NASH is up to 12%, over 16 million US adults, with estimates of a 63% increase by year 2030. ¹⁰
⁸ Belopolsky Y, Khan MQ, Sonnenberg A, Davidson DJ, Fimmel CJ. Ketogenic, Hypocaloric Diet Improves Nonalcoholic Steatohepatitis. J Transl Int Med. 2020;8(1):26-31. Published 2020 May 9. doi:10.2478/jtim-2020-0005
⁹ Promrat K, Kleiner DE, Niemeier HM, et al. Randomized controlled trial testing the effects of weight loss on nonalcoholic steatohepatitis. Hepatology. 2010;51(1):121-129. doi:10.1002/hep.23276
¹⁰ Estes C, Razavi H, Loomba R, Younossi Z, Sanyal AJ. Modeling the epidemic of nonalcoholic fatty liver disease demonstrates an exponential increase in burden of disease. Hepatology. 2018;67(1):123-133. doi:10.1002/hep.29466
Dr. Davidson is a member of Ideal Protein’s Medical Advisory Board.
A 19-week study with the Avera Cancer Institute reported a 40% reduction in C-reactive protein for patients who completed the Ideal Protein Protocol. The study also reported a rapid decline in resting fasting insulin and a mean weight loss of 19.9% body fat. ⁶
Studies show increased CRP levels are associated with a higher risk for inflammatory conditions. ⁷
⁶ Bohlen, Krista & Krie, Amy & Hu, Yueshan & Ageton, Cheryl & Nickles, Heidi & Norfolk, Daniel & Kittelsrud, Julie & Thomes, Reggie & Fahrendorf, Adam & Muth, Jessica & Rojas-Espaillat, Luis & Davies, Gareth. (2013). Low Carbohydrate Dietary Intervention Improves Insulin, Hormonal Levels and Inflammatory Markers in Early Stage, Postmenopausal Breast Cancer Survivors. Cancer Research. 73. 10.1158/0008-5472.SABCS13-PD2-5.
⁷ Pepys MB, Hirschfield GM. C-reactive protein: a critical update. J Clin Invest. 2003;112(2):299. doi:10.1172/JCI200318921C
A study conducted by Aspirus, reported that after 3 years, participants who completed the Ideal Protein Protocol maintained an average weight loss of 12.8%, resulting in an 18% reduction in overall average claim care costs, saving an average of $916.97 per participant, per year. ²
A study published by The American Journal of Clinical Nutrition reports that if individuals can succeed at maintaining their weight loss for 2 or more years, they can reduce their risk of subsequent regain by nearly 50%.³
² Effect of The Ideal Protein Weight Loss Protocol on Employee Health Care Costs, By: Timothy Logemann, MD; David K. Murdock, MD; Kelly O’Heron, RD
³ Rena R Wing, Suzanne Phelan, Long-term weight loss maintenance, The American Journal of Clinical Nutrition, Volume 82, Issue 1, July 2005, Pages 222S, 225S, https://doi.org/10.1093/ajcn/82.1.222S
Dr. Logemann is a member of Ideal Protein’s Medical Advisory Board.
According to a study conducted and published by Aspirus, an eight-hospital health system in Wisconsin and Michigan, entitled Effect of the Ideal Protein Weight Loss Method on Weight Loss and Metabolic Parameters,¹ 233 patients completed at least 12 weeks of the Protocol. The 12-week results were presented at the Cleveland Clinic’s 9th Annual Obesity Summit and at the Annual Scientific Meeting of the National Obesity Society.
Our peer-reviewed, published research demonstrates that, among patients who completed the study, metabolic health can be improved in as little as 12 weeks.
15% ↓
BMI
14% ↓
Total Body Weight*
86% ↓
Dieter Compliance
45% ↓
Triglycerides
14% ↓
Cholesterol
14% ↓
Total Body Weight*
14% ↓
Fasting Glucose
13% ↓
LDL
Study Concludes: The Ideal Protein Protocol produces improvements in blood pressure, lipid profile, particularly in regard to triglyceride levels and fasting glucose levels. The findings suggest that due to the successful weight loss reported, the Protocol could help with cardiovascular risk.
* Total Body Weight -3.5lbs/wk for men and -2.4lbs./wk for women
¹ Effect of the Ideal Protein Weight Loss Method on Weight Loss and Metabolic Parameters By: Timothy Logemann, MD; David K. Murdock, MD, MS; Kelly O’Heron, RD & Adam Hoffmann
Dr. Logemann is a member of Ideal Protein’s Medical Advisory Board.
After 16 weeks on the Ideal Protein Protocol, males lost an average of 25% fat mass while preserving 98% lean body mass and females lost an average 24% of fat mass while preserving 95% lean body mass.⁴
A 2014 Obesity Review states: “Maximizing fat loss while preserving lean tissue mass and function is a central goal of modern obesity treatments. A widely cited rule guiding expected loss of lean tissue as fat-free mass (FFM) states that approximately one-fourth of weight loss will be FFM (i.e. ΔFFM/ΔWeight = ∼0.25), with the remaining three-fourths being fat mass.” 5
⁴ Frank Douglis, MD, Ideal Protein Data Analysis, 2016.
⁵ Heymsfield SB, Gonzalez MC, Shen W, Redman L, Thomas D. Weight loss composition is one-fourth fat-free mass: a critical review and critique of this widely cited rule. Obes Rev. 2014;15(4):310-321. doi:10.1111/obr.12143
Dr. Douglis is an Executive Medical Board Member and Chief Medical Advisor for Ideal Protein.
The Ideal Protein Difference
Ideal Protein is a structured three-phase Protocol designed for long-term weight maintenance. The Weight Loss phase is designed to optimize fat loss through nutritional ketosis, a safe and natural metabolic state in which the body’s primary fuel source is coming from ketone bodies – energy molecules produced by “burning fat.”
Throughout the Weight Loss Phase, lean body mass is preserved through the intake of partial meal replacements, which contain protein of high biological value.
Studies show that to lose and sustain weight loss successfully, there is nothing more important than being assisted by a qualified coach.¹ All coaches are provided ongoing training from Ideal Protein. Through behavior modification and education, our coaches help empower patients with strategies that are critical for long-term healthy weight maintenance.
¹ Sforzo GA, Kaye MP, Todorova I, et al. Compendium of the Health and Wellness Coaching Literature. Am J Lifestyle Med. 2017;12(6):436-447. Published 2017 May 19. doi:10.1177/1559827617708562
The Ideal Protein Protocol combines whole foods with medically designed partial meal replacements. Lean body mass is preserved through an adequate daily intake of high biological protein. Essential nutrients are provided through daily supplements, water, and low-glycemic vegetables. Our products are FDA label approved and meet the Recommended Daily Allowance (RDA) standards for all macro food groups and micro nutritional needs.
Following the Weight Loss Phase (Phase 1), the body’s biological response seeks to regain lost energy stores. The Protocol reduces this response through the Stabilization phase by adjusting macronutrient intake in the right proportions to effectively manage hunger, promote greater satiety, and maintain weight loss.
During the 12-month Maintenance phase, patients continue to receive ongoing education, support, and strategies from their coach and clinic to maintain their weight loss and daily navigate an extensive food landscape.
Ideal Protein’s Medical Advisory Board — comprised of highly regarded medical physicians and industry experts in obesity — provides guidance to healthcare providers who share the same goal of fighting the obesity epidemic through metabolic transformation.
Thousands of healthcare providers across North America offer and recommend Ideal Protein to patients, helping them naturally gravitate to a healthy weight and improved metabolic state.
Featured Products
Our Blog
Are Key People in Your
Navigating Dietary Lifestyle Changes: The Impact of Non-Supportive Spouses and...
Read More
Why Your Mindset is Crucial
Why Your Mindset is Crucial to Weight Loss Success In...
Read More
The Importance of a Solid
The Importance of a Solid Meal Plan While Using Weight...
Read More
